Implementation of Basal–Bolus Therapy in Type 2 Diabetes: A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch with an Insulin Pen
Implementation of Basal–Bolus Therapy in Type 2 Diabetes: A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch with an Insulin Pen
Barriers to mealtime insulin include complexity, fear of injections, and lifestyle interference. This multicenter, randomized controlled trial evaluated efficacy, safety, and self-reported outcomes in adults with type 2 diabetes, inadequately controlled on basal insulin, initiating and managing mealtime insulin with a wearable patch versus an insulin pen. Source: Implementation of Basal–Bolus Therapy in Type 2 Diabetes:... Read more Read more
Could an Anti-Malarial Be an Adjunctive T2D Therapy?
Could an Anti-Malarial Be an Adjunctive T2D Therapy?
Hydroxychloroquine (HCQ, Plaquenil) might be a candidate as adjunctive therapy in type 2 diabetes, researchers reported here. Source: Could an Anti-Malarial Be an Adjunctive T2D Read more
Risk for Cancer Increased in Men, Women With T2DM
Risk for Cancer Increased in Men, Women With T2DM
 Men and women with type 2 diabetes (T2D) have an increased risk for overall cancer and some site-specific cancers, according to a study published online May 9 in the Journal of Read more
Antimalarial drug effective alternative to canagliflozin in type 2 diabetes
Antimalarial drug effective alternative to canagliflozin in type 2 diabetes
Adults with type 2 diabetes inadequately controlled with a DPP-IV inhibitor plus metformin therapy experienced an improvement in glycemic control with the antimalarial drug hydroxychloroquine that was similar to the SGLT2 inhibitor canagliflozin, according to study data presented here. Source: Antimalarial drug effective alternative to canagliflozin in type 2 Read more
A Patient’s Journey: Taming the Glucose Monster
A Patient’s Journey: Taming the Glucose Monster
In a matter of six months, a man went from diabetic levels of A1c to normal levels. Source: A Patient’s Journey: Taming the Glucose Read more
Diabetes education program ‘nudges’ patients toward better health
Diabetes education program ‘nudges’ patients toward better health
A digital health coaching program employing weekly telephone, text messaging and email contacts helped adults with type 2 diabetes lose weight, reduce HbA1c and maintain those benefits for a year, according to study results presented here. Source: Diabetes education program ‘nudges’ patients toward better Read more
Valeritas touts new data for insulin delivery device
Valeritas touts new data for insulin delivery device
Valeritas (NSDQ:VLRX) touted data today from two new studies of its V-Go wearable insulin delivery device in patients with Type II diabetes. In one three-month evaluation of 60 people with Read more
Researchers change clinical practice for infants with diabetes
Researchers change clinical practice for infants with diabetes
Infants with diabetes can drop insulin syringes. This will be new clinical practice after a recent study. Researchers have been leading the work, which causes children worldwide to replace insulin syringes with tablets. Source: Researchers change clinical practice for infants with Read more
Transition Support Program May Aid Young Adults With Type 1 Diabetes
Transition Support Program May Aid Young Adults With Type 1 Diabetes
Structured support for patients transitioning from pediatric to adult care for type 1 diabetes may improve outcomes, but those benefits are not sustained after completion of the Read more
Negative Affect, Diabetes Distress Increase Risk for Binge Eating in Type 1 Diabetes
Negative Affect, Diabetes Distress Increase Risk for Binge Eating in Type 1 Diabetes
Individuals who tend to experience negative affect and diabetes distress before eating are at increased risk for objective binge eating at an upcoming meal. Source: Negative Affect, Read more